The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
Banco Latinoamericano de Comercio Exterior, S. A.
BLX · the NYSE · USD · Market cap $1.9B
Banco Latinoamericano de Comercio Exterior, S.
FAIL · Does not pass the screenPrice as of 28 Oct 2026Daily close, not a live quote
Screened 2026-10-28 · the tape above runs as of 20:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price51.87 USD at the 28 Oct 2026 close
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.35)
- Last reviewed28 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 51.87 against the desk's fair-value range, base estimate 73.00, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.35, read 2026-10-25
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Banco Latinoamericano de Comercio Exterior, S. A. holds its Markdown at $51.87. Consolidating, no directional conviction, held for 338 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 338 days |
| Price at the screen | $51.87 |
| Valuation | 8.61 trailing · 7.41 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.80 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: bank | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Banco Latinoamericano de Comercio Exterior, S. A. does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BLX's ethical verdict changes
Today BLX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 40.7% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus Strong Buy. The average target sits +29% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsTrade finance bank fails our ethical line
Picture a Panama-based lender moving goods across Latin America and the Caribbean. Every deal crosses borders that standard banks often ignore. Yet the business still lands squarely in a sector our screen rejects outright.
Revenue is rising 8 percent, margins sit at 72 percent and return on equity reaches 15 percent. The shares trade at 8.4 times forward earnings with a modest 15 percent gap to our fair value. None of that matters once the ethical filter triggers on banking activity.
Risk sits in the sector exclusion itself plus emerging-market credit cycles that can compress those margins quickly. We pass. Analysis, not advice.
| Forward P/E | 7.4xfairly priced for its growth rate |
| Trailing P/E | 8.6xvery cheap relative to earnings |
| EPS, trailing | 6.06 |
| EPS, forward | 7.04 |
| Revenue growth | +6.2%slow but positive growth |
| Profit margin | 71.2%highly profitable on every dollar of sales |
| Return on equity | 14.7%a solid return on shareholder capital |
| Dividend yield | 434.00% |
| Beta | 0.80steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 38.41 - 63.20 |
| Market cap | $1.9B |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Panama and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBLX trades on the NYSE (the company is based in Panama). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (3 analysts) rates it none, with a mean price target of $66.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Bladex (BLX) Stock Could Be Undervalued On Its Equity Returns Yahoo Finance · 21d ago
- Bladex´s Third Quarter 2026 Conference Call Yahoo Finance · 23d ago
- Bladex Structures USD 1.0 Billion Loan for the Republic of Panama Yahoo Finance · 15 Sep 2026
- Bladex completes successful Debt Issuance in The Mexican Capital Markets Yahoo Finance · 8 Sep 2026
- Bladex Inc (BLX) (Q2 2026) Earnings Call Highlights: Record Portfolio and Net Income Amid ... Yahoo Finance · 25 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $52.95 | +10.1% | · | $1,101 | +10.1% |
| 2 months | $53.67 | +8.6% | $0.69 | $1,099 | +9.9% |
| 3 months | $47.40 | +22.9% | $0.69 | $1,244 | +24.4% |
| 6 months | $43.70 | +33.4% | $1.38 | $1,365 | +36.5% |
| 1 year | $40.29 | +44.6% | $1.38 | $1,480 | +48.0% |
| 2 years | $26.60 | +119.1% | $3.63 | $2,327 | +132.7% |
| 3 years | $17.73 | +228.7% | $5.13 | $3,576 | +257.6% |
| 5 years | $11.59 | +402.7% | $7.13 | $5,642 | +464.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BLX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.